Baker Bros. Advisors LP 13D and 13G filings for Prelude Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-13 4:55 pm Purchase |
2023-12-11 | 13D | Prelude Therapeutics Incorporated PRLD |
Baker Bros. Advisors LP | 10,222,968 24.300% |
3,888 (+0.04%) |
Filing |
| 2023-05-24 4:31 pm Purchase |
2023-05-18 | 13D | Prelude Therapeutics Incorporated PRLD |
Baker Bros. Advisors LP | 10,219,080 19.500% |
92,663 (+0.92%) |
Filing |
| 2021-01-29 4:48 pm Purchase |
2021-01-22 | 13D | Prelude Therapeutics Incorporated PRLD |
Baker Bros. Advisors LP | 10,126,417 28.800% |
5,189 (+0.05%) |
Filing |
| 2020-09-30 5:25 pm Purchase |
2020-09-24 | 13D | Prelude Therapeutics Incorporated PRLD |
Baker Bros. Advisors LP | 10,121,228 31.100% |
10,121,228 (New Position) |
Filing |